V. Kovcin

发表

Perioperative bevacizumab in the treatment of colorectal cancer in patients with liver metastases

D. Radosavljevic, I. Nikolic, Z. Andrić, 2022, Medical review.

BCL10 aberations and NF-kappa B activation involving p65 are absent or rare in primary gastric MALT lymphoma.

O. Markovic, B. Mihaljević, D. Marisavljević, 2014, Vojnosanitetski pregled.

Totally implantable central venous catheters of the port-a-cath type: complications due to its use in the treatment of cancer patients.

S. Dikić, A. Simić, N. Ivanović, 2014, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

Multivariate analysis of prognostic factors in male breast cancer in Serbia.

J. Marinković, S. Šipetić-Grujičić, I. Ratkov, 2014, Asian Pacific journal of cancer prevention : APJCP.

Survival advantage for carboplatin substituting cisplatin in combination with vindesine and mitomycin C for stage IIIB and IV squamous-cell bronchogenic carcinoma: a randomized phase III study.

S. Radulović, S. Jelić, D. Gavrilovic, 2001, Lung cancer.

A review of the international early recommendations for departments organization and cancer management priorities during the global COVID-19 pandemic: applicability in low- and middle-income countries

A. Taghian, A. Kuten, A. Idbaih, 2020, European Journal of Cancer.

Nintedanib plus pemetrexed versus placebo plus pemetrexed in patients with relapsed or refractory, advanced non-small cell lung cancer (LUME-Lung 2): A randomized, double-blind, phase III trial.

N. Hanna, R. Kaiser, M. Ahn, 2016, Lung cancer.

Is chemotherapy necessary in all breast cancer patients?

V. Kovcin, 2009 .

Comparison of the efficacy of two different dosage dacarbazine-based regimens and two regimens without dacarbazine in metastatic melanoma: a single-centre randomized four-arm study

S. Jelić, N. Babović, N. Milanović, 2002, Melanoma research.

PL03.09: Phase 3 Study of Ganetespib, a Heat Shock Protein 90 Inhibitor, with Docetaxel versus Docetaxel in Advanced Non-Small Cell Lung Cancer (GALAXY-2)

R. Ramlau, S. Ramalingam, D. Fennell, 2017 .

A two-step reevaluation of high-dose amsacrine for advanced carcinoma of the upper aerodigestive tract: a pilot phase II study.

S. Jelić, Z. Tomašević, N. Milanović, 1997, Journal of chemotherapy.

Biological and clinical features of non-Hodgkin's lymphoma in the elderly.

O. Markovic, B. Mihaljević, D. Marisavljević, 2012, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

A pilot study to assess the efficacy of salmon calcitonin in the relief of neuropathic pain caused by extraskeletal metastases

S. Jelić, N. Babović, Z. Tomašević, 2004, Supportive Care in Cancer.

Disconnection of chamber and catheter as a complication of central venous catheter type port-a-cath

V. Kovčin, S. Kostić, M. Granić, 2011, Medical oncology.

Randomised study of high-dose epirubicin versus high-dose epirubicin-cisplatin chemotherapy for advanced soft tissue sarcoma.

S. Jelić, N. Babović, N. Milanović, 1997, European journal of cancer.

Association between systemic non-criteria APS manifestations and antibody type and level: results from the Serbian national cohort study.

Z. Mikovic, N. Ilijevski, M. Kontić, 2013, Clinical and experimental rheumatology.

Richter syndrome with emphasis on large-cell non-Hodgkin lymphoma in previously unrecognized subclinical chronic lymphocytic leukemia.

S. Jelić, N. Milanović, M. Marinkovic, 1997, Neoplasma.

Randomized study of zorubicin versus zorubicin-cisplatin in undifferentiated carcinoma of the nasopharynx (UCNT)

S. Jelić, N. Milanović, I. Pendjer, 1997, Annals of oncology : official journal of the European Society for Medical Oncology.

AROME-ESO Oncology Consensus Conference: access to cancer care innovations in countries with limited resources. Association of Radiotherapy and Oncology of the Mediterranean Area (AROME-Paris) and European School of Oncology (ESO - Milan).

F. Cavalli, A. Kuten, M. Aapro, 2019, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

[Comparison of efficiency and toxicity of two chemotherapy protocols in treatment of advanced non-small cell lung cancer].

H. Beculic, M. Musić, Senad Dervišević, 2011, Medicinski pregled.

[Levels of immune complexes in fresh and frozen serum and plasma detected by precipitation with polyethylene glycol in patients with malignant diseases].

Z. Juranić, N. Babović, Z. Tomašević, 1997, Srpski Arhiv za Celokupno Lekarstvo.

Randomized Phase III Study of Ganetespib, a Heat Shock Protein 90 Inhibitor, With Docetaxel Versus Docetaxel in Advanced Non-Small-Cell Lung Cancer (GALAXY-2).

R. Ramlau, S. Ramalingam, D. Fennell, 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Perioperative bevacizumab treatment of colorectal cancer patients with liver metastases: results of RELEVANT observational trial

I. Nikolić, V. Kovčin, Z. Radosavljevic, 2019 .

High-Dose Epirubicin-Cisplatin Chemotherapy for Advanced Soft Tissue Sarcoma

S. Jelić, N. Milanović, Z. Tomašević, 1990, Tumori.

[Evaluation of the efficacy and toxicity of protocol cisplatin, 5-fluorouracil, leucovorin compared to protocol fluorouracil, doxorubicin and mitomycin C in locally advanced and metastatic gastric cancer].

Z. Murtezani, Z. Andrić, S. Kostić, 2012, Srpski arhiv za celokupno lekarstvo.

Efficacy and safety of bevacizumab in combination with oxaliplatin, irinotecan and fluoropyrimidine-based therapy in advanced colorectal cancer

A. Dagović, S. Jezdic, B. Kukic, 2007 .

Efficacy and safety of bevacizumab in combination with oxaliplatin, irinotecan and fluoropyrimidine-based therapy in advanced colorectal cancer

A. Dagović, S. Jezdic, B. Kukic, 2007 .

Therapeutic efficacy and toxicity of bolus application of chemotherapy protocol in the treatment of metastatic colorectal cancer.

B. Pojskić, Alma Mekić Abazović, I. Šišić, 2015, Medicinski glasnik : official publication of the Medical Association of Zenica-Doboj Canton, Bosnia and Herzegovina.